BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 31980882)

  • 1. Mucous membrane pemphigoid-otorhinolaryngological manifestations: a retrospective cohort study.
    Madgar O; Baniel A; Yarom N; Glikson E; Zeeli T; Sprecher E; Alon EE
    Eur Arch Otorhinolaryngol; 2020 Mar; 277(3):939-945. PubMed ID: 31980882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics Associated With Refractory Course, Blindness, and Treatment Strategy-Related Outcomes in Patients With Mucous Membrane Pemphigoid.
    Kridin K; van Beek N; Bühler E; Kochan AS; Ranjbar M; Beissert S; Zillikens D; Günther C; Schmidt E
    JAMA Dermatol; 2023 Feb; 159(2):198-203. PubMed ID: 36630148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single Center Retrospective Study of Patients with Ocular Mucous Membrane Pemphigoid (MMP).
    Morel M; DeGrazia T; Ward L; Behshad S; Kim HJ; Feldman R
    Ocul Immunol Inflamm; 2022 Jan; 30(1):256-261. PubMed ID: 32835566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights into clinical and diagnostic findings as well as treatment responses in patients with mucous membrane pemphigoid: A retrospective cohort study.
    Rashid H; Meijer JM; Bolling MC; Diercks GFH; Pas HH; Horváth B
    J Am Acad Dermatol; 2022 Jul; 87(1):48-55. PubMed ID: 34896128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of mucous membrane pemphigoid: a literature review and update.
    Alrashdan MS; Kamaguchi M
    Eur J Dermatol; 2022 May; 32(3):312-321. PubMed ID: 36065531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucous Membrane Pemphigoid: A Case Report with Oral and Ocular Presentation.
    Fageeh HI
    J Contemp Dent Pract; 2022 Jul; 23(7):755-759. PubMed ID: 36440525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pemphigoid of the mucous membranes. The clinical, histopathological and immunological aspects and current therapeutic concepts].
    Carrozzo M; Broccoletti R; Carbone M; Garzino-Demo P; Gandolfo S
    Minerva Stomatol; 1996 Oct; 45(10):455-63. PubMed ID: 9026690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rituximab Therapy for Mucous Membrane Pemphigoid: A Retrospective Monocentric Study With Long-Term Follow-Up in 109 Patients.
    Bohelay G; Alexandre M; Le Roux-Villet C; Sitbon I; Doan S; Soued I; Shourick J; Rousset L; Mellottee B; Heller M; Lièvre N; Zumelzu C; Morin F; Grootenboer-Mignot S; Gabison E; Caux F; Prost-Squarcioni C; Musette P
    Front Immunol; 2022; 13():915205. PubMed ID: 35844526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmune Subepidermal Bullous Diseases of the Skin and Mucosae: Clinical Features, Diagnosis, and Management.
    Amber KT; Murrell DF; Schmidt E; Joly P; Borradori L
    Clin Rev Allergy Immunol; 2018 Feb; 54(1):26-51. PubMed ID: 28779299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Retrospective Study of Patient-Reported Data of Bullous Pemphigoid and Mucous Membrane Pemphigoid From a US-Based Registry.
    Lee J; Seiffert-Sinha K; Attwood K; Sinha AA
    Front Immunol; 2019; 10():2219. PubMed ID: 31608053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucous Membrane Pemphigoid Causing Central Airway Obstruction.
    Jalil BA; Abdou YG; Rosen SA; Dammad T
    J Bronchology Interv Pulmonol; 2017 Oct; 24(4):334-338. PubMed ID: 28248822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune-mediated subepithelial blistering diseases of mucous membranes. Pure ocular cicatricial pemphigoid is a unique clinical and immunopathological entity distinct from bullous pemphigoid and other subsets identified by antigenic specificity of autoantibodies.
    Chan LS; Yancey KB; Hammerberg C; Soong HK; Regezi JA; Johnson K; Cooper KD
    Arch Dermatol; 1993 Apr; 129(4):448-55. PubMed ID: 7682049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High frequency of upper aerodigestive tract manifestations in mucous membrane pemphigoid.
    Endo H; Rees TD; Niwa H; Kuyama K; Oshima M; Serizawa T; Tanaka S; Iijima M; Komiya M
    Oral Dis; 2022 Sep; 28(6):1555-1560. PubMed ID: 33835636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pemphigoid of the pulmonary system (POPS): A review of a less recognized feature.
    Ahmed AR; Aksoy M; Kinane TB
    Autoimmun Rev; 2022 Nov; 21(11):103180. PubMed ID: 35981700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucous membrane pemphigoid with severe esophageal stricture.
    Barbosa Ldo N; Silva RS; Verardino GC; Gripp AC; Alves Mde F
    An Bras Dermatol; 2011; 86(3):565-8. PubMed ID: 21738978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of pemphigus foliaceus in a mucous membrane pemphigoid patient: An insight into possible mechanism eliciting a distinct autoimmune bullous disease in a rare anti-basement membrane autoimmunity.
    Shimoda-Komatsu Y; Fukui K; Yamazaki Y; Ohyama M
    J Dermatol; 2021 May; 48(5):710-714. PubMed ID: 33725421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ocular mucous membrane pemphigoid].
    Yaïci R; Roth M; Geerling G
    Ophthalmologie; 2023 Jul; 120(7):779-790. PubMed ID: 37318615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucous membrane pemphigoid: nasal and laryngeal manifestations.
    Whiteside OJ; Martinez Devesa P; Ali I; Capper JW
    J Laryngol Otol; 2003 Nov; 117(11):885-8. PubMed ID: 14670151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coexistence of mucous membrane pemphigoid and vitiligo.
    Aithal S; Ganguly S; Kuruvila S
    Indian Dermatol Online J; 2014 Oct; 5(4):485-7. PubMed ID: 25396136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of rituximab in the treatment of mucous membrane pemphigoid: An analytic review.
    Farooq MM; Miloslavsky EM; Konikov N; Ahmed AR
    Autoimmun Rev; 2022 Aug; 21(8):103119. PubMed ID: 35688385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.